WALSIH presents: BioCina Open Door Session

Go behind the scenes, meet experts, and explore partnership and career pathways at a leading Australian CDMO.

BioCina is a global Contract Development and Manufacturing Organisation (CDMO) with deep expertise in small molecules, biologics (microbial, pDNA, mRNA, LNP modalities) delivering integrated drug substance and drug product manufacturing from two GMP facilities in Australia. The Perth facility specialises in sterile fill-finish, covering drug product formulation, aseptic filling and finish operations across multiple formats. With internationally approved facilities and highly experienced teams, BioCina supports innovators from early development through to commercial supply.

This ‘Open Door Session’ of BioCina’s state-of-the-art 14,000m² Perth facility offers a unique opportunity to engage directly with BioCina’s technical experts and a first‑hand look at sterile drug product filling in action.

Attendees will gain insights into manufacturing workflows, quality systems and what collaboration and workforce pathways with BioCina could look like.